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Abstract
The CDC Steven M. Teutsch Prevention Effectiveness Fellowship was started in 1995 to provide 
postdoctoral training in public health economics. This article describes the origins and state of the 
fellowship and the practice of prevention effectiveness research at the Centers for Disease Control 
and Prevention. The fellowship can be seen as one successful example of a demand-driven public 
health innovation to develop crucial capacity for the contemporary health system. Nearly 150 
individuals have been trained through the program since its inception.
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Because resources for public health are limited, research is needed to identify effective and 
efficient investments of these public health funds.1 The Institute of Medicine has outlined 
challenges associated with efficiently allocating health resources.2 It has emphasized the 
importance of all communities enhancing their understanding of what they receive in return 
for their public health investments. The Institute of Medicine has advocated use of economic 
studies to determine the cost, efficiency, cost-effectiveness, and economic influence of 
strategies and interventions to prevent and control disease. The Centers for Disease Control 
and Prevention’s (CDC’s) Director Dr Thomas Frieden commented that “the dissemination 
of accurate information on costs and benefits may be the best way to reduce opposition and 
implement effective public health actions.”3(p1859) However, a trained workforce is required 
to conduct studies that will provide such information. CDC’s Prevention Effectiveness (PE) 
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Fellowship was started in 1995 to provide the agency with the capacity to conduct applied 
public health economics studies. We describe the history and state of the PE fellowship 
(renamed the CDC Steven M. Teutsch Prevention Effectiveness Fellowship in 1997 to 
acknowledge Dr Steven M. Teutsch’s multiple contributions to the field and practice of 
health economics at CDC), as well as illustrate influences that fellows and alumni have had 
regarding public health policy making. Such information will aid other public health 
agencies and academic units to design their own applied public health training programs.
Introducing PE at CDC
During the late 1980s, researchers at CDC began to focus on integrating economic 
evaluation and decision sciences into the work of CDC. Before that, episodic efforts were 
limited to specific studies related to cost-effectiveness of vaccination programs and human 
immunodeficiency virus prevention activities.4–7 When Dr William Roper began his term as 
CDC Director in 1990, his priorities included demonstrating the value of prevention by 
applying tools such as decision analysis, economic evaluation, applied mathematics, and 
modeling to public health challenges.
Drs Roper and Stephen B. Thacker first described applied public health economics at CDC 
in 1990, introducing the term “prevention effectiveness” to the public health literature.8 
They identified the following 5 strategies for making the integration of health economics 
into CDC’s policy planning and program evaluation a practical reality: (1) apply systematic 
strategies for evaluating the effectiveness of prevention; (2) conduct PE assessment by using 
consistent methods for determining outcomes and economic effects; (3) set research 
priorities with prevention in mind; (4) use PE study results to design prevention programs; 
and (5) use effectiveness data more often during policy making. Published articles 
subsequently defined PE tools, including cost analysis, economic evaluations, decision and 
disease transmission modeling, regulatory analysis, and budget impact analysis.9,10
Dr Roper assigned a team to refine the PE concept and its practice. This team, composed of 
epidemiologists, medical doctors, policy analysts, and contracted economists, developed 
trainings and delivered them to CDC program staff and Epidemic Intelligence Service 
officers, hired staff (including CDC’s first full-time economist), performed economic and 
decision science technical assistance for CDC programs, formed the PE Technical Working 
Group, performed an evaluation of how to organize PE activities, and authored the first 
textbook regarding PE methods.11 This team identified PE research at CDC to include the 
use of econometric, decision, simulation, operations analytic, and mathematical modeling to 
describe determinants of health, morbidity, mortality, health inequalities, and health care use 
and expenditure.11 Finally, the team suggested the development of a training program in PE 
that ultimately became the PE fellowship.
CDC Steven M. Teutsch Prevention Effectiveness Fellowship
The PE fellowship emerged from the developmental stage in the early 1990s as a 2-year, 
postdoctoral, applied research and training program in the field of public health economics, 
quantitative policy analysis, and integrative health services research. The PE fellowship 
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mission is “to establish a cadre of quantitative policy analysts at CDC whose work provides 
information for health policy decision makers in CDC, Congress, and nongovernmental 
entities regarding allocation and use of resources to maximize the impact of public health 
programs.” The PE fellowship is unique in that it is an applied research fellowship focusing 
on the application of decision sciences and economics to public health, it is hosted within 
the federal government, it provides fellows with exposure to a wide range of disease and 
programmatic areas, it encourages fellows to collaborate with epidemiologists, it provides 
fellows with opportunities to contribute to emerging public health challenges (bioterrorism, 
pandemic influenza, and Ebola and Zika virus disease), and it has a substantial competency-
based training component. The PE fellowship is responsible for the development of a 
majority of the existing economics and decision science capacity at CDC (Figure 1). For 
example, PE fellowship alumni make up more than 70% of the full-time, PhD-level 
economists at CDC. CDC has more economists than any other operating division of the 
Department of Health and Human Services (https://infogr.am/federal-health-economist?
src=web).
The PE fellowship program welcomed its initial class of 5 fellows in 1995. During 1995–
2015, the PE fellowship trained and graduated 133 fellows in 19 classes and there are 21 
fellows in the 2015 and 2016 classes (Table 1). The fellowship has engaged approximately 
10 fellows per class over the last decade, making the fellowship the largest of its kind in the 
United States. The number of fellows engaged each year is demand-driven and dependent on 
the availability of host organization funds to pay the fellows’ salary, benefits, and other 
expenses. To be eligible for the program, candidates must have a doctoral degree in 
economics, health services research, engineering, public policy, policy analysis, or a related 
quantitatively oriented field. The majority of PE fellows (66%) have been graduates of 
economics programs. Fellows are competitively selected and matched to CDC programs that 
have submitted requests and committed funding. The fellowship routinely receives more 
than 10 eligible, competitive applications for each fellowship position. The fellowship 
advertises through various job Web sites and accepts applications at www.cdc.gov/pef from 
September through January.
Early operational challenges included finding suitable mentors, developing a sustainable 
funding stream, and developing initial administrative policies and procedures. The 
fellowship program has had to respond to the needs of CDC programs to gain stability and 
growth. From 2008 on, the fellowship has engaged an increasing number of graduates from 
noneconomics programs (eg, engineering, operations research, health services research, and 
health policy), evidence of an ever-growing disciplinary diversity of fellows (Figure 2). This 
wider range of disciplines reflects the complex needs of CDC programs. Since the program’s 
inception, fellowship assignments have been evenly divided between infectious disease and 
chronic disease areas at CDC. The majority of fellows (63%) find employment with CDC at 
the conclusion of their fellowships. Fellows who leave CDC at the conclusion of their 
fellowship find positions in academia, state/local health departments, consulting firms, 
pharmaceutical firms, or other public service organizations. As the fellowship has matured, a 
standard set of policies and procedures has emerged; fellows now occupy Title 42 full-time 
equivalent positions at CDC (paid at the GS grade 12, step 1 level), they receive full federal 
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benefits, they are all paired with experienced mentors, and non-US citizens are brought on 
board on a range of visa options.
Fellowship Didactic and Experiential Curriculum
The fellowship training supports a set of competencies that were identified in 2011 and 
includes didactic and experiential components. Five PE competency domains were 
identified: public health science and practice; quantitative analysis; policy analysis and 
communication; interpersonal and professional communications; and foundations of 
leadership. All fellows participate in a program of didactic trainings (Table 2). The 
fellowship’s core didactic curriculum consists of courses taught by CDC scientists and 
external subject matter experts and take up approximately 7% of a fellow’s time. The 
curriculum is continually evaluated and updated to meet the needs of fellows. For example, 
recent additions to the curriculum include Budget Impact Analysis, Regulatory Impact 
Analysis, Introduction to Population Health Science and Practice, and Developing a Policy 
Brief.
PE fellows are assigned to different CDC units where they undertake their experiential 
training—taking a lead role in PE studies, including the assessment of policies, programs, 
and practices by determining their cost, effectiveness, and overall public health influence. 
Fellows are expected to complete a set of performance requirements that demonstrates 
achievement of the competencies. These include authoring 2 scientific papers suitable for 
publication in a peer-reviewed journal, delivering 2 scientific presentations, developing a 
policy brief, and delivering 2 methods-based education sessions. Progress toward completion 
of performance requirements is evaluated by the PE fellowship program, the fellows’ 
supervisor, and the fellows’ mentor on an ongoing basis. Each fellow is assigned a 
nonsupervisory mentor who is an alumnus of the program to provide technical guidance as 
well as support navigating the culture of CDC. In addition to their work with the program to 
which they are assigned, fellows can be deployed to the “field” to participate in outbreak 
responses or other projects.
Influence of the Fellowship
All public health professionals need a basic understanding of economics (particularly cost 
analysis), decision science, and health impact assessment, but the need for a cadre of highly 
skilled professionals to do the rigorous technical work, such as advanced cost-effectiveness 
analyses, modeling, and decision analysis, has been noted.12,13 CDC’s PE fellowship 
program fills a critical public health need by identifying the cost and cost-effectiveness of 
public health interventions and engaging practice and policy leaders in the implementation 
of these interventions. The PE fellowship has been the core resource for building CDC’s 
capacity to assess the effectiveness and value of public health interventions and facilitating 
evidence-based decision making. As mentioned earlier, the vast majority of economists and 
decision scientists at CDC are PE alumni. These scientists have changed the culture at CDC 
and have led the development of the science around public health economics at CDC. PE 
fellowship alumni have authored or coauthored approximately 3700 publications since the 
fellowship started in 1995 (CDC unpublished data, 2016). Programs with teams of 
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economists trained through the PE fellowship have been successful in developing research, 
policies, and practices that have reflected reasonable decisions, respectful of limited health 
resources. The following research by PE fellows and alumni exemplifies the influence of PE 
on population health.
• Demonstrated potential reduction in cost as a result of prevention and health 
promotion. A 2010 Health Affairs publication presented an analysis of the 
estimated cost of adopting a package of 20 proven preventive services (eg, 
tobacco cessation screening, alcohol abuse screening, and daily aspirin use) 
against the estimated savings that could be generated.14 The authors reported that 
greater use of proven clinical preventive services in the United States could avert 
the loss of more than 2 million life-years annually, and increasing the use of 
these services from current levels to 90% could result in total savings of $3.7 
billion, or 0.2% of US personal health care spending. The authors concluded that 
“effective clinical preventive services can achieve the dual goals of improving the 
health of all Americans and making prudent use of scarce resources.”
• Demonstrated influence of CDC programs. Another Health Affairs article from 
2014 presented a historical economic model to measure the net economic 
benefits of preventing central line–associated bloodstream infections in Medicare 
and Medicaid patients in hospital critical care units during 1990–2008, a time 
when reductions attributable to federal investment resulted primarily from CDC 
efforts.15 The authors concluded that CDC central line–associated bloodstream 
infection prevention efforts prevented approximately 40 000 to 75 000 infection 
cases and produced net benefits of at least $640 million during 1990–2008.
• Demonstrated potential lives saved by public health interventions. A recent study 
published in Pediatrics concluded the routine vaccination of children born in 
2009 will prevent 42 000 early deaths and 20 million cases of disease, with net 
savings of $13.5 billion in direct costs and $68.8 billion in total societal costs.16
• Demonstrated enhancements in population health. A 2013 collaboration among 
CDC, the American Cancer Society, and the National Cancer Institute published 
in Preventive Medicine reported implementing a provision of the Affordable 
Care Act—the elimination of cost sharing for recommended preventive services
—resulted in a significantly increased use of these services, particularly for 
blood pressure checks, cholesterol checks, and influenza vaccinations.17
• Demonstrated effectiveness of public health preparedness. CDC developed an 
influential mathematical model to estimate the potential magnitude of the Ebola 
epidemic in West Africa. The model indicated that the possibility existed to 
reverse the epidemic if a sufficient number of Ebola-infected patients were 
effectively isolated, either in treatment units or in other settings.18
The PE fellowship has also provided CDC with the capacity to provide public health 
officials and decision makers with estimates of potential effects of influenza pandemics and 
bioterrorist events, as well as the potential influence of interventions. These analyses have 
enhanced the planning and preparation for such events and influenced the spending of 
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billions of dollars of federal preparedness funds. The first such work coauthored by a PE 
fellow provided an economic analysis of the value of preparing for a bioterrorist event with 
anthrax, tularemia, or brucellosis, which illustrated that substantial societal benefits resulted 
from investing in systems and technologies that allowed rapid responses to such events.19 PE 
fellows also led the first analysis of the potential effect of a 1968-type influenza pandemic 
(ie, what would happen if the 1968 influenza pandemic were to occur now), as well as 
estimating benefits of an influenza vaccination program.20 Perhaps, most important has been 
the translation of various models into basic influenza pandemic planning software, called 
FluAid, FluSurge, FluWorkLoss, FluLabSurge, and CommunityFlu.21,22 Other such 
planning tools produced by PE fellows include those for smallpox or influenza pandemic 
mass vaccination clinics, determining optimal size of the national pediatric vaccine 
stockpile, and planning for medical care needs after a disaster (eg, earthquake or severe 
hurricane).23–25 These tools are online (http://www.cdc.gov/flu/pandemic-resources/tools/
index.htm) and designed to help state and local public health officials plan and prepare for 
the next influenza pandemic. The influence of such tools can be judged, in part, by the fact 
that they have been downloaded approximately 100 000 times (CDC, unpublished data, 
2015).
PE fellows have also provided key support to the 2014–2016 Ebola outbreaks in West 
Africa. Two second-year PE fellows published a study in The Lancet, titled “Preventive 
Malaria Treatment for Contacts of Patients With Ebola Virus Disease in the Context of the 
West Africa 2014–15 Ebola Virus Disease Response: An Economic Analysis.”26 This study 
reported that administration of malaria treatment to contacts of patients with Ebola virus 
disease was cost saving for contacts of all ages in Liberia, Sierra Leone, and Guinea, during 
both seasons, from a health care provider perspective and should be considered by public 
health officials when addressing Ebola virus disease outbreaks in countries and seasons 
where malaria reaches substantial transmission levels.
Conclusion
The influence of public health economics, decision sciences, and modeling at CDC is in 
substantial part attributable to the capacity built through the PE fellowship. In a recent 
supplement to the American Journal of Preventive Medicine, titled “The Use of Economics 
in Informing U.S. Public Health Policy,”27 5 of the 10 articles are coauthored by graduates 
of the PE fellowship program and Dr Steven M. Teutsch coauthored 3 others. This is an 
exceptional addition to the national dialogue around economics and public health policy and 
displays the impact of the PE fellowship. Since its inception in the early 1990s and formal 
beginning in 1995, the PE fellowship has trained fellows, built capacity in various centers 
across CDC, continually updated its public health economics competencies, raised the 
visibility of public health economics, communicated the value of economics and decision 
sciences, and, ultimately, created the capacity in public health economics and decision 
sciences that sets CDC apart from other federal agencies. According to a recent poll of the 
PE fellowship graduates at CDC, 98% agreed or strongly agreed with the statement “I would 
not be here now if it weren’t for the PE fellowship” (CDC unpublished data, 2016). Key 
opportunities for growth involve expanding core economics and decision sciences capacity 
in CDC centers and divisions that do not currently have such capacity; expanding public 
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health economics and decision sciences capacity to state and local health departments; 
continuing to engage the health in all policies agenda28,29; and participating in population 
health initiatives sponsored by CDC and its partners that bring CDC economics and decision 
science expertise to health care providers, community organizations, health payers, and the 
business community. Despite the substantial contributions of the PE fellowship over the past 
20 years, there still exists a considerable gap between existing and needed competency in 
economic evaluation among public health practitioners.30
In his 2014 American Journal of Public Health article, titled “Six Components Necessary for 
Effective Public Health Program Implementation,” CDC Director Frieden underscores the 
importance of PE: “To establish an effective intervention package, it is critical to understand 
the full range of available evidence-based strategies, the size and characteristics of the 
population to be reached, the projected impact of each intervention, and the estimated 
cost.”31(p19) The PE fellowship has been and will continue to be instrumental in developing 
the analytic capacity to provide such assessments and thus improve the science of public 
health.
Acknowledgments
This article is dedicated to Dr Stephen B. Thacker, MD, MPH, who oversaw the development of the field of 
prevention effectiveness and was instrumental in the creation of the Centers for Disease Control and Prevention 
(CDC) Steven M. Teutsch Prevention Effectiveness Fellowship, and ultimately, CDC’s capacity in this area. The 
authors thank Drs Mark Messonnier, Steven M. Teutsch, Scott Grosse, Fatima Coronado, and Kate Glynn for their 
helpful reviews.
References
1. Rein AS, Ogden LL. Public health: a best buy for America. J Public Health Manag Pract. 
2012;18(4):299–302. [PubMed: 22635181] 
2. Institute of Medicine. For the Public’s Health: Investing in a Healthier Future. Washington, DC: 
National Academies Press; 2011 https://iom.nationalacademies.org/~/media/Files/Report%20Files/
2012/For-the-Publics-Health/phfunding_rb.pdf. Accessed February 12, 2016.
3. Frieden TR. The role of government in protecting health and safety. N Engl J Med. 2013;368(20):
1857–1859. [PubMed: 23593978] 
4. Koplan JP, Schoenbaum SC, Weinstein MC, Fraser DW. Pertussis vaccine—an analysis of benefits, 
risks and costs. N Engl J Med. 1979;301(17):906–911. [PubMed: 39253] 
5. Koplan JP, Axnick NW. Benefits, risks and costs of viral vaccines. Prog Med Virol. 1982;28:180–
191. [PubMed: 6806868] 
6. Preblud SR, Orenstein WA, Koplan JP, Bart KJ, Hinman AR. A benefit-cost analysis of a childhood 
varicella vaccination programme. Postgraduate Med J. 1985;61(suppl 4):S17–S22.
7. Snider DE Jr, Caras GJ, Koplan JP. Preventive therapy with isoniazid. Cost-effectiveness of different 
durations of therapy. JAMA. 1986;255(12):1579–1583. [PubMed: 3081740] 
8. Roper WL, Thacker SB. Doing good before there’s harm. Ann N Y Acad Sci. 1993;703(1):33–40. 
[PubMed: 8192314] 
9. Thacker SB, Koplan JP, Taylor WR, Hinman AR, Katz MF, Roper WL. Assessing prevention 
effectiveness using data to drive program decisions. Public Health Rep. 1994;109(2):187–194. 
[PubMed: 8153269] 
10. Centers for Disease Control and Prevention. Assessing the effectiveness of disease and injury 
prevention; costs and consequences. MMWR Recomm Rep. 1995;44(RR-10):1–11.
11. Haddix AC, Teutsch SM, Corso PS. Prevention Effectiveness: A Guide to Decision Analysis and 
Economic Evaluation. 2nd ed. New York, NY: Oxford University Press; 1996:2003.
Skelton and Meltzer Page 7
J Public Health Manag Pract. Author manuscript; available in PMC 2020 February 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
12. Centers for Disease Control and Prevention. Economics and public health at CDC. MMWR Morb 
Mortal Wkly Rep. 2006;55(suppl2):S17–S19.
13. Grosse SD, Teutsch SM, Haddix AC. Lessons from cost-effectiveness research for United States 
public health policy. Ann Rev Public Health. 2007;28:365–391. [PubMed: 17222080] 
14. Maciosek MV, Coffield AB, Flottemesch TJ, Edwards NM, Solberg LI. Greater use of preventive 
services in U.S. health care could save lives at little or no cost. Health Aff (Millwood). 2010;29(9):
1656–1660. [PubMed: 20820022] 
15. Scott D, Sinkowitz-Cochran R, Wise ME, et al. CDC central-line bloodstream infection prevention 
efforts produced net benefits of at least $640 million during 1990–2008. Health Aff (Millwood). 
2014;33(6):1040–1047. [PubMed: 24889954] 
16. Zhou F, Shefer A, Wenger J, et al. Economic evaluation of the routine childhood immunization 
program in the United States, 2009. Pediatrics. 2014;133(4):577–585. [PubMed: 24590750] 
17. Han X, Yabroff KR, Guy GP, Zhenga Z, Jemala A. Has recommended preventive service use 
increased after elimination of cost-sharing as part of the Affordable Care Act in the United States? 
Prev Med. 2015;78:85–91. [PubMed: 26209914] 
18. Meltzer MI, Atkins CY, Santibanez S, et al. Estimating the future number of cases in the Ebola 
epidemic—Liberia and Sierra Leone, 2014–2015. MMWR Surveill Summ. 2014;63(suppl 3):S1–
S14.
19. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are 
prevention and post-attack intervention programs justifiable? Emerg Infect Dis. 1997;3(2):83–94. 
[PubMed: 9204289] 
20. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: 
priorities for interventions. Emerg Infect Dis. 1999;5(5):659–671. [PubMed: 10511522] 
21. Centers for Disease Control and Prevention. Pandemic Flu Preparedness Tools. Preparedness Tools 
for Professionals. Atlanta, GA: US Department of Health and Human Services, Centers for 
Disease Control and Prevention; 2012 http://www.cdc.gov/flu/pandemic-resources/tools/
index.htm. Accessed February 12, 2016.
22. Zhang X, Meltzer MI, Wortley PM. FluSurge—a tool to estimate demand for hospital services 
during the next pandemic influenza. Med Decis Making. 2006;26(6):617–623. [PubMed: 
17099200] 
23. Washington M, Mason J, Meltzer MI. Maxi-Vac: planning mass smallpox vaccination clinics. J 
Public Health Manag Pract. 2005;11(6):542–549. [PubMed: 16224290] 
24. Shrestha SS, Wallace GS, Meltzer MI. Modeling the national pediatric vaccine stockpile: supply 
shortages, health impacts, and cost consequences. Vaccine. 2010;28(38):6318–6332. [PubMed: 
20638451] 
25. Shrestha SS, Sosin DM, Meltzer MI. Planning for medical care needs following a disaster. Disaster 
Med Public Health Prep. 2012;6(4):335–341. [PubMed: 23241463] 
26. Carias C, Greening B, Campbell CG, Meltzer MI, Hamel MJ. Preventive malaria treatment for 
contacts of patients with Ebola virus disease in the context of the West Africa 2014–15 Ebola virus 
disease response: an economic analysis. Lancet Infect Dis. 2016;16(4):449–458. [PubMed: 
26706716] 
27. Glied S, Teutsch SM, Roy K, eds. The use of economics in informing U.S. public health policy. 
Am J Prev Med. 2016:50(5): S1–S84. [PubMed: 27102852] 
28. Rudolph L, Caplan J, Mitchell C, Ben-Moshe K, Dillon L. Health in All Policies: Improving 
Health Through Intersectoral Collaboration. Washington, DC: National Academies Press; 2013.
29. Fielding JE, Teutsch S, Koh H. Health reform and healthy people initiative. Am J Public Health. 
2012;102(1):30–33. [PubMed: 22095359] 
30. Jacob RR, Baker EA, Allen P, et al. Training needs and supports for evidence-based decision 
making among the public health workforce in the United States. BMC Health Serv Res. 
2014;14(1):564. [PubMed: 25398652] 
31. Frieden T. Six components necessary for effective public health program implementation. Am J 
Public Health. 2014;104(1):17–22. [PubMed: 24228653] 
Skelton and Meltzer Page 8
J Public Health Manag Pract. Author manuscript; available in PMC 2020 February 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Implications for Policy & Practice
• Over 20 years, the post-doctoral CDC Steven M. Teutsch Prevention 
Effectiveness Fellowship has been extraordinarily successful at integrating 
new disciplines (health economics and disciplines with similar analytic skills) 
into the already multi-disciplinary field of public health.
• Public health organizations that wish to replicate this success to enhance their 
analytic and mathematical modeling capabilities can use the CDC PE 
Fellowship as a model of how to recruit, suitably train, and successfully 
integrate recent graduates from academia into applied public health settings.
• Key elements to ensure the success of such a program include:
1. a formal, focused, competency-based training program;
2. pre-set fellowship requirements that match closely with the needs of 
the organization (eg, produce manuscripts of immediate use to 
practicing public health officials);
3. identification of supervisors who have both the experience and 
appropriate temperament to supervise fellows;
4. assigning (and training in some cases) mentors that can provide the 
fellows and supervisors with relevant perspective and advice; and, 
finally;
5. the establishment of an office or program whose main task is to 
assure the success of the fellowship.
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FIGURE 1. 
Cumulative CDC Prevention Effectiveness Capacity by Year Attributable to the Prevention 
Effectiveness Fellowship
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FIGURE 2. 
Educational Background (Economics vs Noneconomics) for Fellows of the CDC Prevention 
Effectiveness Fellowship, 1995–2015, by Year of Entry
Abbreviation: CDC, Centers for Disease Control and Prevention.
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TABLE 2
CDC Steven M. Teutsch Prevention Effectiveness Fellowship Didactic Courses by Competency Domaina
Competency Domain Courses
Public health science and practice Introduction to the CDC and History of the CDC
Introduction to Population Health Science and Practice
Quantitative analysis Introduction to Prevention Effectiveness Research
Prevention Effectiveness Research Methods
How to Read and Evaluate Prevention Effectiveness Research
Epidemiology Methods
Introduction to Disease Transmission Modeling
Introduction to Burden and Cost Analysis
Introduction to Economic Evaluation
Introduction to Regulatory Impact Analysis
Introduction to Budget Impact Analysis
Introduction to Health Impact Analysis
Advanced Topics in Decision Analytic Modeling
Cost-effectiveness Analysis the “CDC Way”
Methods for Systematic Reviews of Economics Literature
Introduction to MS Excel for Public Health Modeling
Visual Basic Applications for Excel
Introduction to TreeAge Software
MEPS Data
MedStat/MarketScan Data
Prevention Effectiveness Project Management
Policy analysis and Economics and Policy at CDC
Writing a Policy Brief
Interpersonal and professional Scientific Writing
Developing and Delivering Effective Presentations
Networking for Success
Getting a Job at CDC
Foundations of leadership Action Learning for Professional Development
Fellowship Survival Skills and Navigating the CDC Culture
Fellowship Goal-Setting and Performance-Planning
Abbreviations: CDC, Centers for Disease Control and Prevention; MEPS, Medical Expenditure Panel Survey.
aCourses vary from year to year on the basis of need and resource availability.
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